Home

We are a clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases

To learn more about Erytech's phase 3 clinical trial in pancreatic cancer

To learn more about Erytech's phase 2 clinical trial in Triple Negative Breast Cancer

View the webcast of our KOL event on our lead product, eryaspase, in pancreatic cancer with Dr. Hidalgo and Dr. Noel